Literature DB >> 11026535

The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core.

G Zhou1, M Ferrer, R Chopra, T M Kapoor, T Strassmaier, W Weissenhorn, J J Skehel, D Oprian, S L Schreiber, S C Harrison, D C Wiley.   

Abstract

The three-dimensional structure of the complex between an HIV-1 cell-entry inhibitor selected from screening a combinatorial library of non-natural building blocks and the central, trimeric, coiled-coil core of HIV-1 gp41 has been determined by X-ray crystallography. The biased combinatorial library was designed to identify ligands binding in nonpolar pockets on the surface of the coiled-coil core of gp41. The crystal structure shows that the non-peptide moiety of the inhibitor binds to the targeted cavity in two different binding modes. This result suggests a strategy for increasing inhibitor potency by use of a second-generation combinatorial library designed to give simultaneous occupancy of both binding sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026535     DOI: 10.1016/s0968-0896(00)00155-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.

Authors:  Michael D Miller; Romas Geleziunas; Elisabetta Bianchi; Simon Lennard; Renee Hrin; Hangchun Zhang; Meiqing Lu; Zhiqiang An; Paolo Ingallinella; Marco Finotto; Marco Mattu; Adam C Finnefrock; David Bramhill; James Cook; Debra M Eckert; Richard Hampton; Mayuri Patel; Stephen Jarantow; Joseph Joyce; Gennaro Ciliberto; Riccardo Cortese; Ping Lu; William Strohl; William Schleif; Michael McElhaugh; Steven Lane; Christopher Lloyd; David Lowe; Jane Osbourn; Tristan Vaughan; Emilio Emini; Gaetano Barbato; Peter S Kim; Daria J Hazuda; John W Shiver; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

2.  Evaluation of "credit card" libraries for inhibition of HIV-1 gp41 fusogenic core formation.

Authors:  Yang Xu; Hong Lu; Jack P Kennedy; Xuxia Yan; Laura A McAllister; Noboru Yamamoto; Jason A Moss; Grant E Boldt; Shibo Jiang; Kim D Janda
Journal:  J Comb Chem       Date:  2006 Jul-Aug

Review 3.  Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

Authors:  M L Bellows; C A Floudas
Journal:  Curr Drug Targets       Date:  2010-03       Impact factor: 3.465

4.  Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery.

Authors:  Kent D Stewart; Kevin Steffy; Kevin Harris; John E Harlan; Vincent S Stoll; Jeffrey R Huth; Karl A Walter; Emily Gramling-Evans; Renaldo R Mendoza; Jean M Severin; Paul L Richardson; Leo W Barrett; Edmund D Matayoshi; Kerry M Swift; Stephen F Betz; Steve W Muchmore; Dale J Kempf; Akhter Molla
Journal:  J Comput Aided Mol Des       Date:  2007-02-09       Impact factor: 3.686

Review 5.  Small-Molecule HIV Entry Inhibitors Targeting gp120 and gp41.

Authors:  Fei Yu; Shibo Jiang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein.

Authors:  Dirk Roymans; Hendrik L De Bondt; Eric Arnoult; Peggy Geluykens; Tom Gevers; Marcia Van Ginderen; Nick Verheyen; Hidong Kim; Rudy Willebrords; Jean-François Bonfanti; Wouter Bruinzeel; Maxwell D Cummings; Herman van Vlijmen; Koen Andries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

Review 7.  Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Authors:  Lu Lu; Fei Yu; Lifeng Cai; Asim K Debnath; Shibo Jiang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 8.  Binding of small-molecule ligands to proteins: "what you see" is not always "what you get".

Authors:  David L Mobley; Ken A Dill
Journal:  Structure       Date:  2009-04-15       Impact factor: 5.006

Review 9.  Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Authors:  Fei Yu; Lu Lu; Lanying Du; Xiaojie Zhu; Asim K Debnath; Shibo Jiang
Journal:  Viruses       Date:  2013-01-11       Impact factor: 5.048

10.  Computer-Aided Approaches for Targeting HIVgp41.

Authors:  William J Allen; Robert C Rizzo
Journal:  Biology (Basel)       Date:  2012-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.